PHARMALUNDENSIS AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.36 SEK | +1.69% |
|
-.--% | -20.70% |
| May. 16 | PharmaLundensis AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 15 | PharmaLundensis AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 16.43M 172M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -31.51M | Net income 2023 | -4M -42.01M | EV / Sales 2022 | - |
| Net Debt 2022 | 4.29M 45.06M | Net Debt 2023 | 2.65M 27.86M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-7.32
x | P/E ratio 2023 |
-4.35
x | Employees | 1 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.69% | ||
| 6 months | -21.40% | ||
| Current year | -20.70% |
Current year
0.33
0.56
1 year
0.161.51
3 years
0.162.40
5 years
0.163.40
10 years
0.1611.90
| Managers | Title | Age | Since |
|---|---|---|---|
Staffan Skogvall
FOU | Founder | 61 | 05-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Staffan Skogvall
FOU | Founder | 61 | 05-12-31 |
Arne Skogvall
CHM | Chairman | 92 | - |
Bo Wennergren
BRD | Director/Board Member | 73 | - |
Sector
-
Calendar
2024-08-14
- Q2 2024 Earnings Release (Projected)
- Stock Market
- Equities
- PHAL Stock
